BIO KEY INTERNATIONAL INC Cash Flow Statement
BKYI|7 years of annual SEC 10-K data (FY2011-FY2017)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
BIO KEY INTERNATIONAL INC used $2M in operating cash flow and negative free cash flow of $3M in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Net Income | -$4.3M | -$4.2M | -$1.9M | -$1.9M | -$2.6M | $3.3K | -$1.9M |
| Depreciation & Amortization | - | - | $43.0K | $40.2K | $28.6K | $28.6K | $31.5K |
| Operating Cash Flow | -$2.5M | -$4.4M | -$15.6M | -$2.5M | -$2.7M | $65.6K | -$523.1K |
| Capital Expenditures | $166.1K | $53.0K | $3.4K | $18.6K | $129.4K | - | $56.2K |
| Free Cash Flow | -$2.6M | -$4.5M | -$15.6M | -$2.5M | -$2.8M | - | -$579.3K |
| FCF Margin | -41.8% | -151.2% | -295.8% | -62.9% | -141.7% | - | -16.5% |